Psychiatry · Treatment Modalities (Psychopharmacology, Psychotherapy Basics)

A 30-year-old man with generalized anxiety disorder is started on buspirone. He returns after 3 days complaining that the drug 'is doing nothing.' Which statement about buspirone best explains this encounter?

  • A It is a benzodiazepine receptor antagonist and needs dose escalation
  • B It is a partial agonist at 5-HT1A receptors and requires 2 to 4 weeks for anxiolytic effect
  • C It acts within hours but only at doses above 60 mg/day
  • D It is a full agonist at GABA-A receptors and tolerance develops rapidly
Correct answer: B. It is a partial agonist at 5-HT1A receptors and requires 2 to 4 weeks for anxiolytic effect

Explanation

Buspirone is a partial agonist at presynaptic and postsynaptic 5-HT1A receptors. Like antidepressants, its anxiolytic effect takes 2 to 4 weeks to appear, so early non-response is expected and is not an indication to abandon the drug. It has no affinity for GABA-A or benzodiazepine receptors, which kills options A and D, and it carries no risk of dependence or sedation. This delayed onset is the single most examined fact about buspirone.

Reference: Katzung's Basic and Clinical Pharmacology, 16th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Treatment Modalities (Psychopharmacology, Psychotherapy Basics) MCQs

See all Treatment Modalities (Psychopharmacology, Psychotherapy Basics) MCQs →